So I basically had this in an earlier thread but thought its time we move on to the next thing and quit focusing on the past which we've all rehashed enough at this point.
As this next readout determines SOOOO much of our valuations I'm curious what peoples expectations for it are?
1) GVHD was viewed by all of us as a bit of a "gimme" based on its earlier results.
2) CHF I think is viewed as a "we really don't know" what the outcome will be
So what do we expect honestly from the back pain results? Were our p2 results so overwhelmingly good that we would be stunned if the p3 failed? Or were they just "not bad, pretty decent" and we wouldn't entirely be surprised if we had an LVAD like trial result.
Because lets get real this is the next thing coming thats going to either smash the price to like 50 cents or boost it back to $2 plus.
So we should be discussing this.
Disc Repair (Back Pain Trial)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
0.015(1.40%) |
Mkt cap ! $1.238B | |||
| Open | High | Low | Value | Volume |
| $1.11 | $1.12 | $1.08 | $11.51M | 10.52M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 17804 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 230637 | 5 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.09 |
Change
0.015 ( 1.85 %) |
||||
| Open | High | Low | Volume | ||
| $1.10 | $1.12 | $1.08 | 1937390 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| MSB (ASX) Chart |